20/20 Biolabs, Inc.
AIDX · Services Testing Laboratories
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Bergman Alan B.: Form 4
Insider disclosure · Filed · Report period 02 Apr 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- AIDX · 90138K101 - Common Stock, par value $0.01
Company details and SEC sources
CIK 0001139685 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- AIDX on Nasdaq
- SEC industry group
- Services Testing Laboratories (Industrial Applications and Services)
- Business address
- 9430 Key West Avenue, Suite 100, Rockville, MD, 20850
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- 20/20 GeneSystems, Inc. (to 26 Feb 2025), 20/20 GENE SYSTEMS INC (to 28 Apr 2004)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields